Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 9, 2022

Primary Completion Date

September 3, 2025

Study Completion Date

September 3, 2025

Conditions

Malignant Brain NeoplasmMetastatic Malignant Neoplasm in the BrainRecurrent Malignant Brain Neoplasm

Interventions

DRUG

Dexamethasone

Given IV and PO

Trial Locations (1)

City of Hope Medical Center, Duarte

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER